Do No Harm? Unintended Consequences Of Pharmaceutical Price Regulation In India ArticlesContext: Drug Price Control Order 2013 The Indian Pharmaceutical Market History of Price Regulation in India Details of DPCO 2013 Impact of DPCO on Different Stakeholders Prior Research Results on DPCO 2013 Details of Regulations Post DPCO 2013 Data and Manipulation Checks Terminology Used Data Preparation and Constructed Variables Constructed Variable: Price Reduction of Regulated SKUs Constructed Variable: Detailing Index of Molecules Price Changes of Unregulated SKUs Empirical Results Summary: Pre and Post Regulation Metrics Difference-in-Difference Results Generalized Synthetic Control Method Results Triangulation Results Summary of Results SKU Wise Results Heterogeneity Analysis Mechanism Lower Detailing of Regulated Drugs Decline in Prescriptions by NonMBBS Physicians Survey Evidence on Detailing – Prescription Correlations Alternative Explanations Conclusions